Bart C. Kuenen
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Hematology top 5%
- Co-authors
- Herbert M. PinedoGiuseppe GiacconeMarcel LeviKlaas HoekmanVictor W.M. van HinsberghA.K. KakkarJoost C.M. MeijersRita Ruijter
- Topics
- Cancer Treatment and Pharmacology (8 papers)Angiogenesis and VEGF in Cancer (6 papers)Lung Cancer Treatments and Mutations (6 papers)
- Cited by
- Internal MedicineOncologyHematology
- Journals
- The Journal of Experimental MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bart C. Kuenen
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Oncology 519
- Molecular Biology 511
- Pulmonary and Respiratory Medicine 264
- Cancer Research 176
- Hematology 159
Countries citing papers authored by Bart C. Kuenen
This map shows the geographic impact of Bart C. Kuenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart C. Kuenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart C. Kuenen more than expected).
Fields of papers citing papers by Bart C. Kuenen
This network shows the impact of papers produced by Bart C. Kuenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart C. Kuenen. The network helps show where Bart C. Kuenen may publish in the future.
Co-authorship network of co-authors of Bart C. Kuenen
This figure shows the co-authorship network connecting the top 25 collaborators of Bart C. Kuenen. A scholar is included among the top collaborators of Bart C. Kuenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart C. Kuenen. Bart C. Kuenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 29 | |
| 3 | 66 | |
| 4 | 21 | |
| 5 | 13 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 21 | |
| 9 | 7 | |
| 10 | 9 | |
| 11 | 19 | |
| 12 | 3 | |
| 13 | Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma. | 103 |
| 14 | 91 | |
| 15 | 22 | |
| 16 | 123 | |
| 17 | 109 | |
| 18 | 8 | |
| 19 | 9 | |
| 20 | 82 |
About Bart C. Kuenen
Bart C. Kuenen is a scholar working on Oncology, Hematology and Hepatology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Angiogenesis and VEGF in Cancer (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Internal Medicine (132 citations), Oncology (519 citations) and Hematology (159 citations). Bart C. Kuenen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Herbert M. Pinedo, Giuseppe Giaccone, Marcel Levi, Klaas Hoekman, Victor W.M. van Hinsbergh, A.K. Kakkar, Joost C.M. Meijers, Rita Ruijter, K. Hoekman and Marja Visser. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.